share_log

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga Real-time News ·  Jan 24, 2023 08:08

Gainers

  • Axcella Health (NASDAQ:AXLA) shares rose 64.0% to $0.71 during Tuesday's pre-market session. The market value of their outstanding shares is at $51.8 million.
  • Baudax Bio (NASDAQ:BXRX) stock increased by 30.15% to $4.1. The market value of their outstanding shares is at $2.2 million.
  • Novo Integrated Sciences (NASDAQ:NVOS) stock increased by 26.01% to $0.16. The market value of their outstanding shares is at $9.2 million.
  • Intelligent Bio Solutions (NASDAQ:INBS) shares increased by 22.33% to $1.26. The company's market cap stands at $23.1 million.
  • bioAffinity Technologies (NASDAQ:BIAF) shares rose 16.98% to $1.86. The company's market cap stands at $15.5 million.
  • Genetic Technologies (NASDAQ:GENE) shares moved upwards by 12.8% to $1.11. The company's market cap stands at $17.0 million.

Losers

  • LogicMark (NASDAQ:LGMK) shares fell 35.9% to $0.23 during Tuesday's pre-market session. The company's market cap stands at $2.2 million.
  • Allarity Therapeutics (NASDAQ:ALLR) shares decreased by 17.59% to $0.24. The market value of their outstanding shares is at $3.4 million.
  • Rockwell Medical (NASDAQ:RMTI) stock declined by 14.29% to $1.8. The market value of their outstanding shares is at $20.9 million.
  • Tenax Therapeutics (NASDAQ:TENX) stock decreased by 11.02% to $2.29. The market value of their outstanding shares is at $5.1 million.
  • electroCore (NASDAQ:ECOR) shares fell 8.7% to $0.36. The company's market cap stands at $25.7 million.
  • Sunshine Biopharma (NASDAQ:SBFM) stock fell 8.25% to $0.89. The market value of their outstanding shares is at $20.1 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment